Physician profile

Takuya Saito

Child & Adolescent Psychiatry · Suginami

NPI 1659762060

$64,531.78

in general payments reported to CMS, 2019-2025

2 companies · $4,092 in 2025

The $4,092 reported for 2025 was more than what 97% of Child & Adolescent Psychiatry providers received nationally (typical 2025 total: $132).

See the full distribution for Child & Adolescent Psychiatry

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$13,904.03
Travel and Lodging$2,679.25
Honoraria$2,110.06
Food and Beverage$18.35

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sumitomo Pharma Co., LTD. $57,499.67 2019-2025 Latuda, Latuda
Shionogi INC $7,032.11 2020-2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Takuya Saito

$64,531.78

in general payments reported 2019-2025

Years
2019-2025
Top company
Sumitomo Pharma Co., LTD.
Context
The $4,092 reported for 2025 was more than what 97% of Child & Adolescent Psychiatry providers received nationally (typical 2025 total: $132).

https://glasscript.com/doctor/1313376/takuya-saito

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.